You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR SORBITOL 3.3% IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for SORBITOL 3.3% IN PLASTIC CONTAINER

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000159 ↗ Sorbinil Retinopathy Trial (SRT) Completed National Eye Institute (NEI) Phase 3 1983-08-01 To evaluate the safety and efficacy of the investigational drug sorbinil, an aldose reductase inhibitor, in preventing the development of diabetic retinopathy and neuropathy in persons with insulin-dependent diabetes.
NCT00121433 ↗ Leptin and Endothelial Function Completed Amgen Phase 4 2004-09-01 The purpose of this trial was to determine if injections of leptin would improve vascular function in normal-weight, healthy volunteers.
NCT00121433 ↗ Leptin and Endothelial Function Completed University of Michigan Phase 4 2004-09-01 The purpose of this trial was to determine if injections of leptin would improve vascular function in normal-weight, healthy volunteers.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for SORBITOL 3.3% IN PLASTIC CONTAINER

Condition Name

Condition Name for SORBITOL 3.3% IN PLASTIC CONTAINER
Intervention Trials
Intoxication 2
Severe Mental Illness 2
Constipation 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for SORBITOL 3.3% IN PLASTIC CONTAINER
Intervention Trials
Tooth Diseases 3
Nerve Compression Syndromes 3
Hereditary Sensory and Motor Neuropathy 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for SORBITOL 3.3% IN PLASTIC CONTAINER

Trials by Country

Trials by Country for SORBITOL 3.3% IN PLASTIC CONTAINER
Location Trials
United States 27
China 5
Uzbekistan 4
Ukraine 4
Turkey 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for SORBITOL 3.3% IN PLASTIC CONTAINER
Location Trials
New York 3
Kansas 3
California 3
Washington 2
Ohio 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for SORBITOL 3.3% IN PLASTIC CONTAINER

Clinical Trial Phase

Clinical Trial Phase for SORBITOL 3.3% IN PLASTIC CONTAINER
Clinical Trial Phase Trials
Phase 4 10
Phase 3 6
Phase 2/Phase 3 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for SORBITOL 3.3% IN PLASTIC CONTAINER
Clinical Trial Phase Trials
Completed 16
Recruiting 9
Unknown status 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SORBITOL 3.3% IN PLASTIC CONTAINER

Sponsor Name

Sponsor Name for SORBITOL 3.3% IN PLASTIC CONTAINER
Sponsor Trials
Yuria-Pharm 4
Sahlgrenska University Hospital, Sweden 3
ScandiBio Therapeutics AB 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for SORBITOL 3.3% IN PLASTIC CONTAINER
Sponsor Trials
Other 48
Industry 19
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.